Navigation Links
More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
Date:12/3/2008

cations or interruption for severe or persistent elevations. In Study 1, seventeen (5.7%) patients treated with Exjade developed elevations in SGPT/ALT levels >5 times the upper limit of normal at 2 consecutive visits versus five (1.7%) patients treated with deferoxamine.

Serious hypersensitivity reactions (such as anaphylaxis and angioedema) have been reported in patients receiving Exjade, with the onset of the reaction occurring in the majority of cases within the first month of treatment. If reactions are severe, discontinue Exjade and institute appropriate medical intervention.

Skin rashes may occur during treatment with Exjade. For rashes of mild to moderate severity, Exjade may be continued without dose adjustment, since the rash often resolves spontaneously. In severe cases, Exjade may be interrupted. Reintroduction at a lower dose with escalation may be considered in combination with a short period of oral steroid administration.

Auditory (high-frequency hearing loss, decreased hearing) and ocular (lens opacities, cataracts, elevations in intraocular pressure and retinal disorders) disturbances have been reported with Exjade therapy in less than 1% of patients in clinical trials. Auditory and ophthalmic testing (including slit lamp examinations and dilated fundoscopy) are recommended before the start of Exjade treatment and thereafter at regular intervals (every 12 months). If disturbances are noted, consider dose reduction or interruption.

Gastrointestinal (GI) irritation may occur during Exjade treatment. Upper GI ulceration and hemorrhage have been reported in patients, including children and adolescents, receiving Exjade. Physicians and patients should remain alert for signs and symptoms of GI ulceration and hemorrhage and promptly initiate additional evaluation and treatment if a serious GI adverse event is suspected. Use caution when administering Exjade in combinat
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
4. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
5. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
6. Study Results Reveal alli(R) Patient Satisfaction Linked to Weight Loss Achieved; Not Treatment Effects
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. New Conflict of Interest Violations Revealed at California Stem Cell Institute
9. St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia
10. Protein Tomography(TM) Reveals Molecular Mode of Action of Humax-EGFr Published in PNAS
11. Imaging Results From the ADAGIO-LIPIDS Reveal That Effects of Rimonabant on Cardiometabolic Risk Profile Include Loss of Visceral Fat and Mobilization of Liver Fat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... TARRYTOWN, N.Y. , May 23, 2013 /PRNewswire/ ... reconstruction following mastectomy is an appropriate option ... mutations seeking to surgically reduce their breast cancer ... involves a gradual expansion process and a second ... of implants in the same surgery as mastectomy ...
(Date:5/23/2013)... , May 23, 2013  CAS Medical Systems, Inc. ... devices for non-invasive patient monitoring, today announced that ... will present at the 2 nd Annual Marcum MicroCap ... Hotel in New York City . ... ET in the Estate 10 room and will be available ...
(Date:5/23/2013)... SEATTLE , May 23, 2013  Omeros ... that its Investigational New Drug Application (IND) to ... by the U.S. Food and Drug Administration (FDA). ... expressed in areas of the brain linked to ... including Huntington,s disease and schizophrenia. OMS824 has shown ...
Breaking Medicine Technology:Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4
... LITTLE FALLS, N.J., March 3, 2011 Cantel Medical Corp. ... its second quarter ended January 31, 2011 on Wednesday, March ... to discuss the results at 11:00 AM ET. Participating in ... Krakauer, President and CEO; Seth R. Segel, Executive Vice President; ...
... ConvaTec Healthcare, a world-leading developer, manufacturer and marketer of ... announced that, recognizing favorable conditions in the credit markets, ... a portion of its senior secured term loans originally ... While the year-end audit process is ongoing, ConvaTec presently ...
Cached Medicine Technology:Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its Second Quarter Ended January 31, 2011 2ConvaTec Healthcare Announces Plans to Refinance Secured Term Loans 2ConvaTec Healthcare Announces Plans to Refinance Secured Term Loans 3
(Date:5/23/2013)... Tucson, AZ (PRWEB) May 23, 2013 Looking ... when dealing with the sensitive issue of caring for your ... Professional Geriatric Care Managers (NAPGCM) released the results of ... on this question. , Here are the ... survey (along with the percentage of survey respondents selecting each ...
(Date:5/23/2013)... New York (PRWEB) May 23, 2013 As ... recall of Rejuvenate and ABG II Modular-Neck Hip Stems continue ... notes that new research has found a connection between the ... tissue destruction. The study, which was published on May ... at 12 hips in 11 patients who reported new-onset ...
(Date:5/23/2013)... researchers have discovered that the daily clearance of neutrophils ... cells from the bone marrow into the bloodstream, according ... Cell ., Neutrophils are leukocytes (white blood cells) that ... disease organisms. To perform their function, these cells release ... However, release of these substances in the wrong place ...
(Date:5/23/2013)... To kick off barbecue season, fire up the grill ... calories with simple tips from Retrofit weight loss . ... summer. , “The powerful heat of the grill can be ... are not mindful of your selections, it can be as ... Amy Margulies. , Margulies advises clients to choose healthy options ...
(Date:5/23/2013)... A medical Internet marketing consulting service has ... of the medical and healthcare community to help them ... consulting service is focused on SEO and a number ... marketing agency is providing the service to help clients ... of the consulting, the company will draw on its ...
Breaking Medicine News(10 mins):Health News:New Survey of Aging Experts Gives Top 5 Tips for Avoiding Family Feud when Caring for Aging Parents 2Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Comments on Research Linking Femoral Stem Corrosion at Modular-Neck Junction with Local Soft Tissue Destruction 2Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Comments on Research Linking Femoral Stem Corrosion at Modular-Neck Junction with Local Soft Tissue Destruction 3Health News:Discarded immune cells induce the relocation of stem cells 2Health News:Fire It Up! Master Calories at the Grill with Retrofit Weight Loss 2Health News:Fire It Up! Master Calories at the Grill with Retrofit Weight Loss 3Health News:Healthcare Internet Marketing Consulting Services Launched by JD Media Surge 2
... Inc. (NYSE: WLP ), the,nation,s largest ... today the expansion of its innovative disease management ... members in its affiliated health,plans suffering from Bipolar ... each year. The Bipolar Condition Care Program will ...
... NuVasive, Inc. (Nasdaq: NUVA ), a medical device ... for the spine, announced today that Alex Lukianov, Chairman and ... Annual J.P. Morgan Healthcare Conference at the Westin St. Francis ... at 11:00 a.m. PT.A live Web cast of the presentation ...
... will begin the new year in his new role as ... and father of two, brings his experience to one of ... from the Beaumont, TX area. He attended Lamar University ... minor in cultural anthropology. Equal Health has been in business ...
... When , Music industry veteran and TV personality Randy ... a second year to help people living with type 2 ... to encourage them to enroll in The Heart of ... is coming to Philadelphia to urge the tens of thousands ...
... & Roll Hall of Fame inductees Jackson Browne and ... the nation,s biggest problem: the health of our peopleWASHINGTON, ... company, and The Vineeta Foundation, a health and human ... Obama,s Inauguration, the Health for All Blue Diamond Ball ...
... The Center for Sleep and Pulmonary Medicine Opens in Southwest ... the health of patients with a wide variety of sleep ... The Center for Sleep and Pulmonary Medicine in Southwest Florida. ... at 700 2nd Ave. N, Suite 305, Naples, FL 34102 ...
Cached Medicine News:Health News:WellPoint Announces Innovative Program to Help Improve the Care of Members Suffering With Bipolar Disorder 2Health News:WellPoint Announces Innovative Program to Help Improve the Care of Members Suffering With Bipolar Disorder 3Health News:NuVasive to Present at 27th Annual J.P. Morgan Healthcare Conference 2Health News:Equal Health Hires Experienced VP Chandler 2Health News:Randy Jackson and the American Heart Association Encourage Philadelphia Residents to 'Get In The K.N.O.W.' About Improving Type 2 Diabetes Management 2Health News:Health for All Blue Diamond Ball Scheduled to Celebrate Obama's Inauguration 2Health News:Dr. Mitchell L. Petusevsky, M.D., F.C.C.P. Meets Growing Demand for the Treatment of Sleep and Pulmonary Disorders 2
The KAVD Venous Cannula is the first of its kind. It is a combination of cannulae/venous line designed to "bridge the gap between the patient and the Medtronic Resting Heart System circuit....
... Medtronic Select CAP® cannulae provides a ... pressure readings. An innovative combination of ... monitoring line, the Select CAP® can ... central arterial pressure readings on which ...
Intermittent catheter...
Intermittent catheter...
Medicine Products: